SCHEMBL5607430

SCHEMBL5607430

CCCO/C(=C\c1ccc(OCc2ccccc2)cc1)C(=O)OCC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.72
ALDH1A1 P00352 2/20 0.55
LMNA P02545 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
RAB9A P51151 2/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
NPC1 O15118 1/20 0.48
GAA P10253 1/20 0.48
GSK3B P49841 2/20 0.48
BACE1 P56817 2/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
ALOX5 P09917 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PTPN1 P18031 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAOB P27338 2/20 0.46
NR4A1 P22736 1/20 0.45
NR4A2 P43354 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607439 1.00 NR1H4 (0.72) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL5607538 0.95 NR1H4 (0.68) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL5607535 0.95 NR1H4 (0.68) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL5607211 0.95 NR1H4 (0.64) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL5607214 0.95 NR1H4 (0.64) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL5607732 0.94 NR1H4 (0.70) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL5607736 0.94 NR1H4 (0.70) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL2804642 0.93 NR1H4 (0.79) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL2804643 0.93 NR1H4 (0.79) NR1H4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL2807676 0.93 NR1H4 (0.79) NR1H4ALDH1A1LMNAL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885ALDH1A1 5/4885LMNA 1420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.